Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Journal of Clinical Psychopharmacology|September 16, 2006
Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective studyMaria A Rettenbacher, Susanne Baumgartner, Ursula Eder-Ischia, et al.
Cancer|March 11, 2003
Fatigue in ovarian carcinoma patients: a neglected issue?Bernhard Holzner, Georg Kemmler, Verena Meraner, et al.
Lancet (London, England)|February 11, 2017
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trialGyörgy Németh, István Laszlovszky, Pál Czobor, et al.
The Journal of Clinical Psychiatry|January 20, 2004
Olanzapine induces insulin resistance: results from a prospective studyChristoph F Ebenbichler, Markus Laimer, Ursula Eder, et al.
Brain and Cognition|December 19, 2006
The neural regions sustaining episodic encoding and recognition of objectsAlex Hofer, Christian M Siedentopf, Anja Ischebeck, et al.
Psychiatry Research|November 9, 2005
Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patientsAlexandra B Whitworth, Georg Kemmler, Michaela Honeder, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychoticsNursen Yalcin-Siedentopf, Fabienne Wartelsteiner, Alexandra Kaufmann, et al.
CNS Drugs|September 11, 2025
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized TrialMatin Mortazavi, Zahra Aminifarsani, Inge Winter-van Rossum, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 10, 2017
Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilienceA Hofer, Y Mizuno, F Wartelsteiner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 8, 2018
Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) studyPierre-Michel Llorca, Julio Bobes, W Wolfgang Fleischhacker, et al.
Pageof 18